Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Neurology. 2018 Apr 24;90(17):777-788. doi: 10.1212/WNL.0000000000005347.
Neurology. 2018.
PMID: 29686116